Form 8-K - Current report:
SEC Accession No. 0000950170-25-095310
Filing Date
2025-07-11
Accepted
2025-07-11 16:30:29
Documents
10
Period of Report
2025-07-09
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K drrx-20250709.htm   iXBRL 8-K 56206
  Complete submission text file 0000950170-25-095310.txt   166502

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT drrx-20250709.xsd EX-101.SCH 29455
12 EXTRACTED XBRL INSTANCE DOCUMENT drrx-20250709_htm.xml XML 4539
Mailing Address 10240 BUBB ROAD CUPERTINO CA 95014
Business Address 10240 BUBB ROAD CUPERTINO CA 95014 4087771417
DURECT CORP (Filer) CIK: 0001082038 (see all company filings)

EIN.: 943297098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31615 | Film No.: 251119324
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)